1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

10 Oct 2022
Admin
News Article

The China Nmpa Approves Selpercatinib For The Treatment Of Patients With Ret-Driven Lung And Thyroid Cancers

Innovent Biologics, Inc. A World-Class Biopharmaceutical Company That Develops, Manufactures And Commercializes High-Quality Medicines For The Treatment Of Cancer, Metabolic, Autoimmune, Ophthalmology And Other Major Diseases, Is Pleased To See That The National Medical Products Administration (Nmpa) Of China Has Approved The New Drug Application (Nda) For Selpercatinib (40Mg & 80Mg Capsules) For The Treatment Of Adult Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (Nsclc) With A Rearranged During Transfection (Ret) Gene Fusion, Adult And Pediatric Patients 12 Years Of Age And Older With Advanced Or Metastatic Medullary Thyroid Cancer (Mtc) With A Ret Mutation Who Require Systemic Therapy, And Adult And Pediatric Patients 12 Years Of Age And Older With Advanced Or Metastatic Thyroid Cancer (Tc) With A Ret Gene Fusion Who Require Systemic Therapy And Who Are Radioactive Iodine-Refractory (If Radioactive Iodine Is Appropriate).Selpercatinib Is A Selective And Potent Ret Kinase Inhibitor That Was Discovered And Developed By Eli Lilly And Company. In March 2022, Innovent And Lilly Expanded Their Strategic Partnership In Oncology, Which Includes An Agreement For Innovent To Obtain The Sole Commercialization Rights Of Selpercatinib Once Approved In China, Positioning Innovent To Be Fully Responsible For The Pricing, Importation, Marketing, Distribution And Detailing Of This Product. With This Further Expanded Oncology Product Portfolio, Innovent Intends To Use Its Experienced Oncology Commercial Team To Leverage Its Broad Commercial Coverage In Hospitals And Pharmacies At Various Tiers And To Provide Integrated Patient Solutions With Strong Synergies To Cancer Patients In China.Selpercatinib Was Globally The First Ret Inhibitor Granted Accelerated Approval By The Fda In May 2020,[1] Under The Brand Name Retevmo

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!